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Abstract
Liver cirrhosis is the irreversible stage in liver damage process which occurs after liver fibrosis due to necro-
inflammatory activities and liver fibrosis. Therefore, inhibition of liver inflammation and fibrosis is very important 
to prevent liver cirrhosis. This study aimed to analyze the effect of ethanol extract of propolis (EEP) from mount 
Lawu, Indonesia to prevent liver damage and fibrosis progression in mice with hepatic cirrhosis. This study was performed during the period of June 2018 to May 2019 on a sample of 32 male Balb/C mice divided into 
control group (P1), induction of carbon tetrachloride (CCl4 ) group (P2), induction of 50 mg/BW CCl4 + EEP group 
(P3), and (induction of 100 mg/KgBW CCl4 + EEP (P4) with each group consisted of eight mice. The CCl4 in olive 
oil was administered intraperitoneally three times a week for six weeks. Mean differences between group was 
determined using ANOVA test with a significance level of 0.05.  The induction of CCl4  increased liver cell damage 
and serum alanin aminotransferase (ALT) level. However, the addition of EEP significantly (p<0.001) reduced 
liver cell damage as seen in P3 (54.38±4.17 per 100 liver cells) and P4 (37.13±4.36 per 100 liver cells) groups and 
serum alanin aminotransferase (ALT) as seen in P3 (291.19±113.92 U/L) and P4 (229.38±73.45 U/L) groups. The 
APRI scores were also reduced after EEP as seen in P3 (0.738±0.292) and P4 (0.513±0.253) groups. Thus, EEP 
isolates from Gunung Lawu can reduce liver cell damage and fibrosis in mice model of hepatic cirrhosis.
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Abstrak
Sirosis hati (SH) merupakan tahap ireversibel dalam proses kerusakan hati yang terjadi setelah fibrosis hati 
sebagai hasil aktivitas nekroinflamasi dan fibrosis hati. Oleh karena itu, penghambatan inflamasi hati dan fibrosis 
sangat penting untuk mencegah terjadi SH. Penelitian ini bertujuan menganalisis efek ekstrak etanol isolat 
propolis (EEP) gunung Lawu dalam mencegah progresifitas kerusakan dan fibrosis hati pada mencit model SH. 
Penelitian dilakukan di Laboratorium Histolgis Fakultas Kedokteran Universitas Sebelas Maret Surakarta dan 
Lembaga Penelitian dan Pengujian Terpadu (LPPT) Universitas Gajah Mada Yogyakarta. Penilitian ini dilakukan 
periode Juni 2018 sampai Mei 2019, dengan sampel 32 ekor mencit Balb/C jantan dibagi menjadi kelompok 
(P1) kontrol negatif, (P2) induksi karbon tetraklorida (CCl4 ), (P3) induksi CCl4 +EEP dosis 50 mg.kgBB-1, dan 
(P4) induksi CCl4 +EEP dosis 100 mg.kgBB-1, dengan tiap-tiap sampel terdiri atas delapan ekor mencit Balb/C 
jantan. CCl4 dalam minyak zaitun diberikan pada tikus Balb/C tiga kali seminggu selama enam minggu secara 
intraperitoneal. Uji ANOVA digunakan untuk menentukan perbedaan rerata antarkelompok dengan tingkat 
kemaknaan sebesar 0,05. Namun, penambahan EEP secara signifikan (p<0,001) menurunkan tingkat kerusakan 
sel hati seperti yang terlihat pada P3 (54,38±4,17 per 100 sel hati) dan kelompok P4 (37,13±4,36 per 100 sel hati) 
dan serum alanin aminotransferase (ALT) seperti yang terlihat dalam kelompok P3 (291,19±113,92 U/L) dan P4 
(229,38±73,45 U/L). Hasil skor APRI menunjukkan kelompok P1(0,213±0,113) dan P2 (0,863±0,534), EEP dapat 
menurunkan skor APRI pada kelompok P3 (0,738±0,292) dan P4 (0,513±0,253). Simpulan, EEP isolat Gunung 
Lawu menurunkan tingkat kerusakan sel hati dan fibrosis pada mencit model SH.
Kata kunci: Kerusakan hepar, propolis, SGPT, sirosis hepatis, skor APRI
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Introduction
Liver cirrhosis, a final pathway of various chronic liver diseases, is a pathologic entity 
defined as diffuse hepatic fibrosis with normal liver architecture replacement by nodules.1 Liver 
fibrosis is attributed to inflammation, excessive 
accumulation of extracellular matrix (ECM), and tissue remodeling under wound healing.2,3 Chronic hepatitis and liver cirrhosis are positively associated with the occurrence of hepatocellular carcinoma; therefore, the inhibition of hepatic 
inflammation and fibrosis is crucial to prevent liver cirrhosis and hepatocellular carcinoma. 
The Aspartate Aminotransferase Platelet Ratio 
Index (APRI) score is a simple non-invasive 
diagnostic tool for predicting liver fibrosis and cirrhosis.4 Hence, this score can be used to compare the possibility of progressing into 
liver fibrosis and cirrhosis in different groups of patients.
Hepatotoxicity of carbon tetrachloride 
(CCl4) involves its biotransformation into free radicals such as trichloromethyl free radical 
(CCl3) and trichloroperoxyl radical, which may 
increase lipid peroxidation.3,4
Propolis as a natural product derived from plant resins collected by honey bees has a number of biological activities, such as 
anti-inflammatory and antioxidant activities. 
Antioxidant activities of propolis are especially 
due to its flavonoid content (caffeic acid 
phenethyl ester/CAPE).5 CAPE can also inhibit 
the nuclear factor NF-κB pathway.6 Biological, 
geographical, and environmental zone factors can affect the amount and quality of propolis production.7 Identification of the main active 
ingredient in the ethanol extract of Mount Lawu propolis isolates had been able to identify the 
CAPE content of 30.24±3.53 x 10-6 grams and 
quercetin content of 4.42±0.50 x 10-6 grams.8 
This information is used to determine the propolis dose. A study has shown that, as an 
anti-inflammatory agent, the ethanol extract from Mount Lawu propolis isolates decreases 
the High-Mobility Group Box 1 (HMGB-1) in mice model of male infertility whereas as an 
antioxidant, the dose of 100 mg.kgBW-1. day-1 
for 30 days reduces the malondialdehyde (MDA) 
level as one of the biomarkers of oxidative stress 
and increases superoxide dismutase (SOD) as 
one of the main intracellular antioxidant defense mechanisms.9,10,11 Propolis is expected to have the effect of inhibiting the progression of liver 
fibrosis into liver cirrhosis. 
The purpose of this study was to analyze the 
effect of ethanol extract of propolis (EEP) from mount Lawu isolates in preventing liver damage 
and fibrosis progression in mice model with liver cirrhosis.
Methods
This was a laboratory experimental study conducted at the Histology Laboratory of the Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia and the Integrated 
Research and Testing Institute of Gajah Mada 
University, Yogyakarta, Indonesia. This study was conducted in the period of June 2018 to May 2019 on a total of 32Balb/C mice weighing 15−20 g and aged 4−6 weeks which were purchased from the Laboratory Animal House 
of Setya Budi University, Surakarta. The mice 
were kept for 2 weeks to be acclimatized before 
the commencement of the experiment. All mice 
were kept in a cage with saw dust covered floor 
that was placed  in a quiet and temperature-
controlled room (23±4°C). Standard diet was provided ad libitum. All protocols regarding this study have been approved by the the health research ethics committee through the issuance 
of the ethical clearance number 96/UN27.6/
KEPK/2018. The experiment was conducted according to the ethical guidelines for the use of 
animals in laboratory experiments of the Faculty of Medicine, Sebelas Maret University, Surakarta.
Mice were randomly divided into 4 experimental groups with 8 mice per group: a control group 
consisting mice fed with standard diet (P1), mice treated with CCl4 (2 mL/kgBW, of 2: 5 v/v in 
olive oil, intraperitonially) three times a week for 
six weeks (P2), (mice treated with daily dose of CCl4+ EEP (50 mg.kgBW-1) via gastric tube (P3) and mice treated with daily dose of CCl4+EEP 
(100 mg.kgBW-1) via gastric tube (P4)y. 12,13On the 42nd day, the mice were sacrificed. Liver tissue was removed and histopathological preparations were made according to the standard method of the Histology Laboratory of the Faculty of Medicine, Sebelas Maret University, 
Surakarta, for histopathological examinations 
(liver fibrosis). Serum collection for serum alanin 
aminotransferase (ALT) examination, serum 
aspartate aminotransferase (AST), and platelets was performed to determine the degree of liver 
damage and fibrosis using the APRI scores.
APRI score is a simple diagnostic tool for 
predicting fibrosis and cirrhosis.4 APRI score 
measurement uses an APRI calculator tool with the following formula: 
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Figure 1 Comparison of the Average Number of Liver Cell Damage (per 100 Liver Cells) between  
   Sample Groups (**p <0.01)
APRI=
The bee propolis in this study was obtained 
from beekeepers in Kerjo, Karanganyar, 
Surakarta, Central Java, Indonesia. Extraction was carried out using the percolation method with 
80% ethanol extraction liquid. Approximately 
1 g (weighing accuracy of up to 0.0001 g) raw 
propolis powder was extracted with 10 mL of 80% ethanol in a shaker at a speed of 200 rpm 
at room temperature for 24 hours. After filtering 
using a filter paper, filtrate was gained  up to 25 
mL with 80% ethanol. This filtrate was stored in bottles until analysis.
Data obtained were analyzed using the SPSS 
for Windows Release 15 program and p<0.05 
was chosen as the minimum level of significance. ANOVA test or alternative was used for data analysis.
Results
Results showed that, at the cellular level, the level of liver cell damage in the control mice 
group was 30.25±4.62 per 100 liver cells. CCl4 induction significantly increased liver 
cell damage to 75.00±5.93 per 100 liver cells 
(p<0.001). This evidence of liver cell damage was strengthened by the results of biochemical 
examination showing the increase of ALT level 
from 71.25±18.14 U/L in the control group 
into 305.25±121.44 U/L (p<0.001) in the CCl4 
induced group. Provision of EEP was able to 
significantly reduce liver cell damage (p<0.001), both cellularly and biochemically, which was 
apparent from the results in the P3 group with 
an EEP dose of 50 mg/kgBW/day/orally and P4 
group with a dose of 100 mg/kgBW/day/orally 
of 54.38±4.17 per 100 cells liver and ALT levels 
291.19±113.92 U/L in P3 and 37.13±4.36 per 
100 liver cells and ALT levels 229.38±73.45 U/L 
in P4. The difference in the average rate of liver cell damage between sample groups is depicted 
below (Figure 1).
Based on the variable description of ALT and 
AST levels, it was revealed that CCl4 induction increased the mean liver cell damage when 
compared to the control group. Providing EEP to mice that have been induced by CCl4 can reduce 
the average liver cell damage. The differences in 
average liver cell damage based on ALT and AST levels between groups of samples are described 
below (Figure 2 and 3).
Results of the meta-analysis concluded that 
the APRI score greater than 1.0 has a sensitivity 
of 76% and a specificity of 72% to predict 
cirrhosis. In addition, the APRI score greater 
than 0.7 has a sensitivity of 77% and a specificity 
of 72% to predict liver fibrosis.14 The results of 
the antifibrosis analysis in this study showed 
that the average APRI score of the control 
((AST level (IU/L))
(AST (Upper Limit of Normal)(IU/L)))
(Platelet count (109/L)) x 100
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Figure 2 Comparison of ALT Levels between Sample Groups (ns: Non-Significant)
Figure 3 Comparison of AST Levels Between Sample Groups (ns: Non-Significant)
group was 0.213±0.113. Induction of CCl4 
(p=0.042) increased the average APRI score to 
0.863±0.534. The administration of EEP therapy 
at a dose of 50 mg/kgBW/day (P3) and 100 mg/
kgBW/day (P4) reduced the average APRI score 
to 0.738±0.292 (p=0.936) and E 0.513±0.253 
(p=0.385), respectively, when compared to the 
liver cirrhosis group (P2). These results indicate 
that the level of liver fibrosis or cirrhosis can 
be suppressed by EEP, albeit insignificantly. 
This is probably because fibrosis is a reversible 
process. This study showed used the following 
APRI score definition: normal (APRI <0.5), 
fibrosis (APRI 0.5 to <1.0), and cirrhosis (APRI 
>1.0). The formation of liver fibrosis was seen in 25% of mice with 50% of them took the form 
of liver cirrhosis after 42 days. The provision of 
EEP with a dose of 50 mg/kgBW/day was able to reduce the degree of liver cirrhosis, which 
emphasizes the correlation between the degree 
of liver cirrhosis and increasing EEP dose. The differences in the degree of liver cirrhosis based 
on APRI scores between groups are described as 
follows (Figure 4).
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Figure 4 Comparison of Liver Cirrhosis Degree by APRI Scores between Sample Groups
DiscussionMany studies have used CCl4 to induce liver 
cirrhosis in experimental animal. The liver damage due to the administration of CCl4 starts with its binding to the hepatocyte cell membrane 
receptor which then stimulates the NADPH 
enzyme located in the mitochondria to form 
reactive oxygen species (ROS). This process is 
similar to the initial stage (incubation period/
sub-clinical) of the disease process. The liver tissue damage in this study can be detected at both biochemical and cellular levels. At the biochemical level, the detection was done through changes in serum alanine transaminase 
(ALT/AST) levels that was measured using the 
enzymatic photometric methods as well as through the capillary thrombocyte level as the 
indicator of liver injury. At the cellular level, the damage was detected histologically.
Carbon tetrachloride as a hepatotoxic material 
is destructive to liver cells. The administration of CCl4 causes a multifactor effect on the liver, 
including its toxic effects triggered by reactive 
metabolites, ROS, inflammatory reactions, and imbalances between cellular damage and protection responses which ultimately result 
in inflammation, oxidative stress induction 
and fibrosis in the liver.15,16 A single dose of CCl4 causes centrizonal necrosis and steatosis while prolonged administration will lead to 
liver fibrosis, cirrhosis, and hepatocellular 
carcinoma. CCl4 directly damages hepatocytes by changing plasma, lysosomal, and mitochondrial membrane permeabilities. Highly reactive free radical metabolism is also formed by the 
oxidation system in hepatocytes via CYP2E1, causing severe centrilobular necrosis.17
Carbon tetrachloride is one of the xenobiotics that has been reported to induce acute and 
chronic tissue injuries through bioactivation of 
the phase I cytochrome P450 system to form reactive metabolic trichloromethyl radicals 
(·CCl3) and peroxy trichloromethyl radicals 
(·OOCCl3). These free radicals can covalently bind to macromolecules such as proteins, lipids,and 
nucleic acids. The double allylic hydrogen 
bonds of polyunsaturated fatty acid (PUFA) are susceptible to abstraction by free radicals; CCl4 exposure induces an increase in lipoperoxide 
and free peroxide radical concentrations that are 
highly reactive and cause injury or necrosis.2,3,18Based on the epistomology approach 
principles that refer to previous findings, this 
study showed that the long-term administration of CCl4,  i.e. 42 days, caused liver damage which begins with the necrosis of liver cells. In the 
liver cirrhosis group,  there was a significant increase in liver damage which was evident from 
increased number of liver cells that experienced 
pycnosis, karyorrhexis, and karyolysis. The administration of CCl4 triggers liver necrosis 
due to lipid peroxidase and free radicals which eventually leads to hydropic degeneration, 
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separate cell structures, and pycnotic cell 
nuclei (karyopyknosis), namely cell nucleus 
shrinkage and chromatin condensation. The cell 
then undergoes karyorrhexis and karyolysis.
This study showed normal conditions of liver 
cells with pycnosis (18.3±2.8%), karyorrhexis 
(8.5±2.9%) and karyolysis (3.5±1.4%). The administration of CCl4 increased the process of 
necrosis that  liver cells experienced pycnosis 
(47.4±6.4%), karyorrhexis (14.3±3.9%), and 
karyolysis (14.6±4.2%). The administration 
of EEP was able to reduce the rate of liver cell 
damage based on the finding that the EEP dose of 100mg/kgbw/day can reduce the necrosis 
process by decreasing pycnosis (15.9±2.5%), 
karyorrhexis (12.4±2.4%), and karyolysis 
(8.9±1.9%). Cellular results were strengthened by 
biochemical results, namely  significant increase 
in ALT levels after he administration of CCL4. 
Likewise, the provision of EEP can reduce the 
increase in ALT levels. The occurrence of necrosis causes liver cell to undergo karyolysis that will 
trigger the formation of pathogen-associated 
molecular patterns (PAMPs). These PAMPs will then activate the immune response through 
oxidative stress pathways, growth factors, and 
inflammation. In the end, this will stimulate the liver cells to become active, thus triggering the 
liver fibrogenesis process or final stage of liver 
cirrhosis. In this study, the process of fibrogenesis or liver cirrhosis was seen indirectly through the 
measurement of APRI scores as a non-invasive 
predictor of fibrogenesis or liver cirrhosis. The provision of CCL4 significantly increased APRI scores, meaning that it accelerates the process of 
fibrogenesis and liver cirrhosis which is in line 
with the research of Khan et al.18 that induction 
using CCL increases ALT and liver cell DNA fragmentation. 4 Meanwhile, the administration 
of EEP was able to reduce the APRI score or 
suppress the occurrence of fibrogenesis and 
liver cirrhosis processes. This reduction was 
in parallel with the increase dose of EEP. An 
EEP dose of 100 mg/kgBW/day was able to inhibit liver cell damage and the process of 
fibrogenesis and liver cirrhosis in a significant 
way. Unfortunately, no APRI score reference is 
available for experimental animals. 
The induction of CCl4 in mice increases liver cell thickness, which is apparent from the 
increase in ALT and AST levels and the level 
of liver cell thickness. The CCl4 causes acute 
hepatocyte injury, alters membrane integrity 
and, as a result, leakage of hepatocyte enzyme. 
After the administration of EEP, the pathological 
increase in ALT, AST and liver cell level can 
significantly be prevented. This indicates that 
EEP has the ability to protect against CCl4-
induced hepatocyte (hepatoprotective) injury as also mentioned in previous studies that reported the protective effect of CCl4-induced polyphenol compounds on liver cirrhosis.18 The same result was also reported by Susanto et al.10,11 stating that the administration of Gunung Lawu propolis 
isolate with a dose of 100 mg/kgBW/day, reduced 
malondialdehyde (MDA) as one of the oxidative 
stress biomarkersand increased superoxide 
dismutase (SOD) as one of the main mechanisms 
of intracellular antioxidant defense.10,11
Based on the axiological principle, the overall 
benefit of the results of this study is that EEP 
can prevent or reduce the hepatotoxic effects, 
including fibrogenesis and liver cirrhosis. EEP can reduce the occurrence of liver cirrhosis through the mechanism of biological activities 
such as anti-inflammatory and antioxidants. 
Antioxidant activities of propolis, especially 
the CAPE content,  has a hepatoprotective nature due to its biological activities such as 
cytoprotective, anti-oxidant, anti-proliferative, 
and anti-inflammatory properties which have 
been shown to inhibit lipoxygenase activity and 
lipid peroxidation. 5,19 CAPE can also inhibit the 
NF-κB transcription factor.In conclusion, the administration of Mount Lawu propolis isolates from Indonesia can 
significantly reduce the level of liver cell damage, both cellularly and biochemically, and reduce the 
APRI score in the liver cirrhosis mice model. This indicates that Indonesian propolis isolates have 
hepatoprotector and antifibrosis properties in 
liver cirrhosis. Therefore, it is possible to use 
theIndonesian propolis isolates as an adjuvant therapy to inhibit the development of liver cirrhosis disease. However, further research 
is needed to measure the degree of fibrosis molecularly or cellularly.
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